Junie Chea

551 total citations
18 papers, 348 citations indexed

About

Junie Chea is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junie Chea has authored 18 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junie Chea's work include Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Medical Imaging Techniques and Applications (4 papers). Junie Chea is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Medical Imaging Techniques and Applications (4 papers). Junie Chea collaborates with scholars based in United States, South Korea and United Kingdom. Junie Chea's co-authors include John E. Shively, Erasmus Poku, David Colcher, Paul J. Yazaki, Nicole Bowles, Michael R. Weist, Jeffrey Y.C. Wong, Saul J. Priceman, Renate Starr and Brenda Aguilar and has published in prestigious journals such as Blood, Scientific Reports and IEEE Access.

In The Last Decade

Junie Chea

18 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junie Chea United States 12 161 142 105 91 59 18 348
Wen‐Ting K. Tsai United States 10 155 1.0× 130 0.9× 80 0.8× 88 1.0× 49 0.8× 13 317
Adam Badar United Kingdom 11 104 0.6× 69 0.5× 112 1.1× 60 0.7× 40 0.7× 15 327
Nir Rozenblum Israel 8 64 0.4× 147 1.0× 100 1.0× 102 1.1× 105 1.8× 15 479
Jake C. Forster Australia 8 106 0.7× 81 0.6× 92 0.9× 114 1.3× 23 0.4× 12 345
Christina S. Fjeldbo Norway 11 64 0.4× 70 0.5× 188 1.8× 79 0.9× 27 0.5× 18 424
Komal Mandleywala United States 10 159 1.0× 115 0.8× 106 1.0× 65 0.7× 28 0.5× 16 345
Brandon M. Bordeau United States 10 201 1.2× 256 1.8× 101 1.0× 35 0.4× 61 1.0× 15 380
Mihaela Popa Norway 13 54 0.3× 123 0.9× 195 1.9× 186 2.0× 38 0.6× 25 507

Countries citing papers authored by Junie Chea

Since Specialization
Citations

This map shows the geographic impact of Junie Chea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junie Chea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junie Chea more than expected).

Fields of papers citing papers by Junie Chea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junie Chea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junie Chea. The network helps show where Junie Chea may publish in the future.

Co-authorship network of co-authors of Junie Chea

This figure shows the co-authorship network connecting the top 25 collaborators of Junie Chea. A scholar is included among the top collaborators of Junie Chea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junie Chea. Junie Chea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Kujawski, Maciej, Mark E. Sherman, Susanta Hui, et al.. (2020). Potent immunomodulatory effects of an anti-CEA-IL-2 immunocytokine on tumor therapy and effects of stereotactic radiation. OncoImmunology. 9(1). 1724052–1724052. 17 indexed citations
3.
Wong, Patty, Lin Li, Junie Chea, et al.. (2020). Antibody Targeted PET Imaging of 64Cu-DOTA-Anti-CEA PEGylated Lipid Nanodiscs in CEA Positive Tumors. Bioconjugate Chemistry. 31(3). 743–753. 18 indexed citations
4.
Li, Lin, Paul J. Yazaki, Junie Chea, et al.. (2020). Improved targeting of an anti‐TAG‐72 antibody drug conjugate for the treatment of ovarian cancer. Cancer Medicine. 9(13). 4756–4767. 15 indexed citations
5.
Li, Daneng, Rebecca S. Allen, James R. Bading, et al.. (2020). Preclinical PET Imaging of NTSR-1-Positive Tumors with 64 Cu- and 68 Ga-DOTA-Neurotensin Analogs and Therapy with an 225 Ac-DOTA-Neurotensin Analog. Cancer Biotherapy and Radiopharmaceuticals. 36(8). 651–661. 4 indexed citations
6.
Li, Lin, Paul J. Yazaki, Junie Chea, et al.. (2020). TAG-72–Targeted α-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody. Journal of Nuclear Medicine. 62(1). 55–61. 21 indexed citations
7.
Filippov, Aleksandr, et al.. (2020). Role of theranostics in thoracic oncology. Journal of Thoracic Disease. 12(9). 5140–5146. 5 indexed citations
8.
Kujawski, Maciej, Lin Li, S. Bhattacharya, et al.. (2019). Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy. BMC Cancer. 19(1). 882–882. 17 indexed citations
9.
Mikhaylova, Ekaterina, Farouk Nouizi, Maciej Kujawski, et al.. (2019). Prototype Small-Animal PET-CT Imaging System for Image-Guided Radiation Therapy. IEEE Access. 7. 143207–143216. 9 indexed citations
10.
Li, Junfeng, Jeffrey Rawson, Junie Chea, et al.. (2019). Evaluation of [68Ga]DO3A-VS-Cys40-Exendin-4 as a PET Probe for Imaging Human Transplanted Islets in the Liver. Scientific Reports. 9(1). 5705–5705. 17 indexed citations
11.
Yazaki, Paul J., Thinzar M. Lwin, Lin Li, et al.. (2019). Improved antibody-guided surgery with a near-infrared dye on a PEGylated linker for CEA-positive tumors. Journal of Biomedical Optics. 24(6). 1–1. 21 indexed citations
12.
Weist, Michael R., Renate Starr, Brenda Aguilar, et al.. (2018). PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine. Journal of Nuclear Medicine. 59(10). 1531–1537. 105 indexed citations
13.
Kumar, Bijender, Indu Nair, Junie Chea, et al.. (2018). 64cu-DOTA-Anti-CD33 PET-CT Imaging for Acute Myeloid Leukemia and Image-Guided Treatment. Blood. 132(Supplement 1). 2747–2747. 1 indexed citations
14.
Li, Lin, Junie Chea, Erasmus Poku, et al.. (2017). Diagnostic PET Imaging of Mammary Microcalcifications Using 64Cu-DOTA-Alendronate in a Rat Model of Breast Cancer. Journal of Nuclear Medicine. 58(9). 1373–1379. 11 indexed citations
15.
Wong, Patty, Lin Li, Junie Chea, et al.. (2017). Synthesis, Positron Emission Tomography Imaging, and Therapy of Diabody Targeted Drug Lipid Nanoparticles in a Prostate Cancer Murine Model. Cancer Biotherapy and Radiopharmaceuticals. 32(7). 247–257. 13 indexed citations
16.
Wong, Patty, Lin Li, Junie Chea, et al.. (2017). PET imaging of 64Cu-DOTA-scFv-anti-PSMA lipid nanoparticles (LNPs): Enhanced tumor targeting over anti-PSMA scFv or untargeted LNPs. Nuclear Medicine and Biology. 47. 62–68. 30 indexed citations
17.
Kim, Min Kyu, Seongwoo Han, Byoung Kwon Lee, et al.. (2013). Apparent treatment-resistant hypertension among elderly Korean hypertensives: an insight from the HIT registry. Journal of Human Hypertension. 28(3). 201–205. 3 indexed citations
18.
Yazaki, Paul J., Divya Channappa, Chi Wai Cheung, et al.. (2012). A series of anti-CEA/anti-DOTA bispecific antibody formats evaluated for pre-targeting: comparison of tumor uptake and blood clearance. Protein Engineering Design and Selection. 26(3). 187–193. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026